- Significant cost reduction compared to traditional technologies
- The ability to read DNA molecules up to megabases in size
- The scalability and portability
- The potential to directly detect base modifications
“The ability to quickly obtain accurate genome sequences of eukaryotic pathogens at low costs provides a tremendous opportunity to identify novel targets for therapeutics, develop pesticides with increased target specificity and breed for resistance in food crops,” says Nathalie van Orsouw, VP Technology Development, KeyGene.
“Using the MinION sequencer we have demonstrated our ability to deliver a eukaryotic fungal genome sequence at low cost within a week. The upcoming PromethION system will enable KeyGene to cost-efficiently generate assemblies of both plant and pathogen genomes at population-scale and low cost,” says Erwin Datema, Scientist, KeyGene.
For more information:
KeyGene Netherlands
Alexander Wittenberg
[email protected]
www.keygene.com